You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥師幫(09885.HK)2024年淨利3001.3萬元 同比扭虧為盈
格隆匯 03-17 22:14

格隆匯3月17日丨藥師幫(09885.HK)公吿,截至2024年12月31日止年度,集團錄得收入人民幣179.04億元,同比增加5.5%。收入增加主要歸因於報吿期內自營業務持續穩定發展。公司擁有人應占利潤3001.3萬元,同比扭虧為盈;每股盈利0.05人民幣元。董事會建議派付截至2024年12月31日止年度末期股息每股人民幣0.075元(相當於0.081港元。

報吿期內,受藥品零售市場整體增速放緩影響,公司的業務雖然面臨挑戰,但仍實現了穩步增長。通過精準洞察用户需求、構建全場景服務體系、數字化賦能的不斷優化,公司持續提升用户體驗,增強用户粘性,推動業務增長。截至2024年12月31日,公司的累計註冊買家數超過827,000家,其中藥店491,000家,基層醫療機構330,000家。報吿期內,公司的月均活躍買家數433,000家,同比增長18.0%。月均付費買家數達401,000家,同比增長17.2%。公司的付費率,即月均付費買家數佔月均活躍買家數的比達到了92.7%,且每個付費買家月均訂單數約28.5單。

展望2025年,在我國加速推進"健康中國"建設、醫療健康普惠可及的大背景下,藥師幫將不斷在院外醫藥產業領域強化和鞏固公司現有平台業務和自營業務的根基。同時,公司將持續推進AI技術在醫藥產業鏈上下游的廣泛普及與深度應用,着力實現服務品質的躍升,全方位賦能用户,進一步挖掘潛在增長動力、拓寬發展空間。依託卓越的數字技術和數字運營實力,公司將持續致力於為千千萬萬的商家、藥店以及基層醫療機構帶來普惠可及、便捷高效的健康服務體驗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account